OHE Tomoyuki

写真a

Affiliation

Faculty of Pharmacy, Department of Pharmacy 薬学教育研究センター (Shiba-Kyoritsu)

Position

Professor

External Links

Career 【 Display / hide

  • 1996.04
    -
    1997.03

    日本学術振興会 特別研究員

  • 1997
    -
    1999

    万有製薬株式会社(MSD) つくば研究所 創薬研究所

  • 1999
    -
    2000

    Merck Research Laboratories(West Point, PA, USA)

  • 2000
    -
    2009

    万有製薬株式会社(MSD) つくば研究所 薬物動態研究所

  • 2009
    -
    2011

    大鵬薬品工業株式会社 創薬センター 分子標的薬研究所

display all >>

Academic Background 【 Display / hide

  • 1992.03

    The University of Tokyo, Faculty of Pharmaceutical Science, 製薬化学科

    University, Graduated

  • 1994.03

    The University of Tokyo, Graduate School, Division of Pharmaceutical Sciences, 生命薬学

    Graduate School, Completed, Master's course

  • 1997.03

    The University of Tokyo, Graduate School, Division of Pharmaceutical Sciences, 生命薬学

    Graduate School, Completed, Doctoral course

Academic Degrees 【 Display / hide

  • PhD, The University of Tokyo, Coursework, 1997.03

Licenses and Qualifications 【 Display / hide

  • 薬剤師, 1992

 

Research Areas 【 Display / hide

  • Life Science / Pharmaceutical chemistry and drug development sciences (Chemical Pharmaceutical Science)

  • Life Science / Pharmaceutical analytical chemistry and physicochemistry

  • Life Science / Pharmaceutical hygiene and biochemistry

Research Keywords 【 Display / hide

  • 創薬化学

  • drug metabolism

  • 分析化学

  • pharmacokinetics

  • antioxidant

display all >>

Research Themes 【 Display / hide

  • Strategic Drug Design to Eliminate Metabolic Activation of Hapatotoxic Drugs, 

    2011
    -
    Present

  • Lead optimization considering drug metabolism, 

    2012
    -
    Present

  • 反応性代謝物を捕捉する新規トラッピング剤の開発, 

    2017
    -
    Present

  • 臓器標的型プロドラッグ戦略の開発, 

    2018
    -
    Present

  • Synthesis of fullerene derivatives and their biological activities, 

    2011
    -
    Present

display all >>

 

Books 【 Display / hide

Papers 【 Display / hide

  • KMN003 activates Nrf2 via disruption of the Keap1-Nrf2 interaction and p38-dependent transcriptional regulation

    Keijiro Komeda, Kai Toyoshima, Daisuke Yasuda, Hanako Ishida, Koujin Kojima Masanori Osawa, Tomoya Hirano, Tomoyuki Ohe, Kenji Tago, Megumi Funakoshi-Tago

    Cellular Signalling 137   112194 2026.01

    Research paper (scientific journal), Accepted

  • Development of Keap1-Nrf2 Protein-protein Interaction Inhibitor Activating Intracellular Nrf2 Based on the Naphthalene-2- acetamide Scaffold, and its Anti-inflammatory Effects

    Daisuke Yasuda, Kai Toyoshima, Koujin Kojima, Hanako Ishida, Kazuma Kaitoh, Riyo Imamura, Kayoko Kanamitsu, Hirotatsu Kojima, Megumi Funakoshi-Tago, Masanori Osawa, Tomoyuki Ohe, Tomoya Hirano

    ChemMedChem 20 ( 21 ) e202500474 2025.09

    Research paper (scientific journal), Joint Work, Accepted

  • Development of a fluorescent-labeled trapping reagent to evaluate the risk posed by acyl-CoA conjugates

    Shibazaki C., Mashino T., Ohe T.

    Drug Metabolism and Pharmacokinetics  52   100509 2023.10

    Research paper (scientific journal), Joint Work, Last author, Corresponding author, Accepted

  • Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease

    Katagishi D., Yasuda D., Takahashi K., Nakamura S., Mashino T., Ohe T.

    Bioorganic and Medicinal Chemistry Letters 80   129121 2023.01

    Research paper (scientific journal), Joint Work, Last author, Corresponding author, Accepted

  • Development of p62-Keap1 protein–protein interaction inhibitors as doxorubicin-sensitizers against non-small cell lung cancer

    Daisuke Yasuda, Ippei Yoshida, Riyo Imamura, Daiki Katagishi, Kyoko Takahashi, Hirotatsu Kojima, Takayoshi Okabe, Yoshinobu Ichimura, Masaaki Komatsu, Tadahiko Mashino, Tomoyuki Ohe

    Results in Chemistry 4   100609 2022.10

    Research paper (scientific journal), Joint Work, Last author, Accepted

display all >>

Papers, etc., Registered in KOARA 【 Display / hide

display all >>

Reviews, Commentaries, etc. 【 Display / hide

  • Drug discovery of safer benzbromarone derivatives

    Tomoyuki Ohe

    BIO Clinica (北隆館)  35 ( 2 ) 59 - 62 2020.02

    Article, review, commentary, editorial, etc. (scientific journal)

  • Drug discovery of safer drugs by eliminating metabolic activation of existing drugs

    Tomoyuki Ohe

    Precision Medicine (北隆館)  2 ( 9 ) 47 - 51 2019.08

    Article, review, commentary, editorial, etc. (scientific journal), Single Work

  • 反応性代謝物とその評価.

    Ohe T.

    日本薬理学雑誌 (日本薬理学会)  134   338-341 2009.12

    Article, review, commentary, editorial, etc. (scientific journal), Single Work

  • Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.

    Hochman JH, Yamazaki M, Ohe T, Lin JH.

    Curr Drug Metab (Bentham Science Publishers)  3   257-273 2002.06

    Article, review, commentary, editorial, etc. (scientific journal), Joint Work

Presentations 【 Display / hide

  • Nrf2活性化剤KMN003の効率的合成法の確立と抗炎症効果の検証

    節家 千聖、米田 慶二郎、豊島 海、安田 大輔、平野 智也、 小島 行人、石田 英子、大澤 匡範、大江 知之、多胡 憲治、 多胡めぐみ

    [Domestic presentation]  日本薬学会第146年会 (大阪) , 

    2026.03

    Poster presentation

  • 内在性dsRNA誘導により抗腫瘍作用を有する薬剤の探索と作用機序の解明

    市川大樹、上岡優菜、松下麻衣子、大江知之

    [Domestic presentation]  日本薬学会第146年会, 

    2026.03

    Poster presentation

  • ナフタレン-2-アセトアミド構造を有する新規Nrf2活性化剤の創製 ―ピロリジン型アセトアミドの有用性―

    安田大輔、多胡めぐみ、小島行人、 石田英子、大澤匡範、大江知之、平野智也

    [Domestic presentation]  第75回日本薬学会関西支部大会, 

    2025.10

    Oral presentation (general)

  • 紫外線照射によるヒト表皮角化細胞傷害に対するフラーレン誘導体の防御効果

    山地 菜月、片岸 大紀、片岡 裕樹、大江 知之

    [Domestic presentation]  第69回日本薬学会関東支部大会, 

    2025.09

    Poster presentation

  • 薬学部生を対象とした「価値観」尺度の開発および評価

    和田 悠佑、鹿島田 和大、横田 恵理子、大江 知之

    [Domestic presentation]  第10回日本薬学教育学会大会, 

    2025.08

    Poster presentation

display all >>

Research Projects of Competitive Funds, etc. 【 Display / hide

  • 細胞内移行型反応性代謝物トラッピング剤の開発

    2025.04
    -
    2028.03

    文部科学省, 科学研究費補助金, Principal investigator

  • Development of a novel drug for Parkinson’s disease with neuroprotective effects

    2023.04
    -
    2025.03

    AMED, 橋渡し研究プログラムpreF, Commissioned research, Principal investigator

  • 新型コロナウイルス感染症治療薬を目指した新規フラーレン誘導体の創製

    2021.04
    -
    2025.03

    文部科学省, 挑戦的研究(萌芽), Research grant, Principal investigator

  • 既存薬を基盤とした臓器標的型プロドラッグの創製

    2021.04
    -
    2022.03

    福澤基金研究補助, Research grant, Principal investigator

  • 探索段階における反応性代謝物リスク評価法の開発

    2020.10
    -
    2021.09

    旭化成ファーマ株式会社, A-COMPASS, Joint research, Principal investigator

display all >>

Intellectual Property Rights, etc. 【 Display / hide

  • パーキンソン病治療薬

    Date applied: PCT/JP2020/003462  2020.01 

    Date announced: WO/2020/158870  2020.06 

    Patent, Joint

  • パーキンソン病治療薬

    Date applied: 特願2019-014281  2019.01 

    Patent, Joint

  • 潰瘍性大腸炎の予防または治療剤と新規フラーレン誘導体

    Date applied: PCT/JP2014/053950  2014.02 

    Date announced: WO2014/129513  2014.08 

    Patent, Joint

  • 潰瘍性大腸炎の予防または治療剤と新規フラーレン誘導体

    Date applied: 特願2013-030455  2013.02 

    Patent, Joint

 

Courses Taught 【 Display / hide

  • SPECTROSCOPY IN ORGANIC CHEMISTRY

    2025

  • RESEARCH FOR BACHELOR'S THESIS 1

    2025

  • RESEARCH APPARATUS LABORATORY COURSE

    2025

  • PHARMACY SEMINAR

    2025

  • PHARMACEUTICAL-ENGLISH SEMINAR

    2025

display all >>

Courses Previously Taught 【 Display / hide

  • C4(4)化学物質の構造決定

    Keio University

    2015.04
    -
    2016.03

    Autumn Semester, Lecture, Within own faculty, 200people

  • C5(1)官能基の導入・変換

    Keio University

    2015.04
    -
    2016.03

    Spring Semester, Lecture, Within own faculty, 200people

  • C5(2)複雑な化合物の合成

    Keio University

    2015.04
    -
    2016.03

    Autumn Semester, Lecture, Within own faculty, 200people

  • C6(1)生体分子のコアとパーツB

    Keio University

    2015.04
    -
    2016.03

    Spring Semester, Lecture, Within own faculty, 200people

  • 精密有機合成

    Keio University

    2015.04
    -
    2016.03

    Autumn Semester, Lecture, Within own faculty, 60people

display all >>

Educational Activities and Special Notes 【 Display / hide

  • スタンダード薬学シリーズⅡ 化学系薬学 Ⅱ生体分子・医薬品の化学による理解 日本薬学会編 東京化学同人 

    2016.04

    , Development of Textbook and Teaching Material

 

Social Activities 【 Display / hide

  • 日本薬学会関東支部幹事

    日本薬学会関東支部

    2023.02
    -
    Present
  • 薬学協議会薬科学担当教員会議

    2020.12
    -
    Present
  • Editorial Advisory Board for Drug Metabolism and Pharmacokinetics

    2020.04
    -
    Present
  • 芳香族アミン取扱事業所で発生した膀胱がんの業務上外に関する検討会検討委員

    厚生労働省

    2020.02
    -
    2021.03
  • 日本薬物動態学会代議員

    2014.04
    -
    Present

Memberships in Academic Societies 【 Display / hide

  • 日本分析化学会, 

    2016
    -
    Present
  • 日本酸化ストレス学会, 

    2012
    -
    Present
  • 日本薬物動態学会, 

    2008
    -
    Present
  • 日本薬学会(医薬化学部会), 

    1992
    -
    Present

Committee Experiences 【 Display / hide

  • 2025.10
    -
    Present

    薬学部日吉主任, 慶應義塾大学薬学部

  • 2025.10
    -
    Present

    薬学部運営委員会委員, 慶應義塾大学薬学部

  • 2023.04
    -
    Present

    薬学教育研究センター運営委員会委員長, 慶應義塾大学薬学部

  • 2014.04
    -
    Present

    CBT実施委員長, 慶應義塾大学薬学部

  • 2023.04
    -
    Present

    実習委員会委員長, 慶應義塾大学薬学部

display all >>